Menu
Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 15
Original Research
Alpha-1 Antitrypsin Augmentation Therapy Improves Survival in Severely Deficient Patients with Predicted FEV1 Between 10% and 60%: A Retrospective Analysis of the NHLBI Alpha-1 Antitrypsin Deficiency Registry
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 8,840 | Dovepress* | 7,840+ | 673 | 8,513 | |
| PubMed Central* | 1,000 | 316 | 1,316 | ||
| Totals | 8,840 | 989 | 9,829 | ||
| *Since 3 December 2020 | |||||
View citations on PubMed and Google Scholar